AACR 2023: Enzyme shows promise as target to treat HPV negative head and neck cancer
Vinita Takiar’s lab in UC’s Department of Radiation Oncology studies how to improve radiation therapy…
Browsing: AACR
AACR 2022: Using AI to predict side effects from new anticancer drug combinations
Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new…
AACR 2022: Two drugs targeting DNA damage response show promise in early-stage cancer trials
Results from early-stage clinical trials show two drugs that target the DNA damage response (DDR)…
AACR 2022: Team of scientists and clinicians wins global award for transforming breast cancer treatment
A group of UK clinical and non-clinical scientists working together across different areas of cancer…
AACR 2022: Paediatric cancer patients in lower-and middle-income countries faced significantly higher mortality risk during the COVID-19 pandemic
During the first nine months of the COVID-19 pandemic, paediatric cancer patients from lower-and middle-income…
AACR 2022: An AI model may predict elevated pancreatic cancer risk using electronic health records
An artificial intelligence (AI) model trained using sequential health information derived from electronic health records…
AACR 2022: KRAS G12C inhibitor sotorasib may offer long-term clinical benefit in patients with non-small cell lung cancer
Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras)…
AACR 2022: AURORA study identifies molecular features tied to breast cancer tumour spread
Susana Garcia-Recio, PhD, a research associate in the lab of Charles M. Perou, PhD, at…
AACR 2022: Novel COVID-19 vaccine may provide protection for cancer patients with B-cell deficiencies
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients…
AACR 2022: Lung cancer patients with a genetic variant linked to autoimmune disease may respond better to immunotherapy
A variant of the CTLA-4 gene associated with autoimmune disease was found to be more…